文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

复发型多发性硬化症患者的工作生产力:与残疾、抑郁、疲劳、焦虑、认知和健康相关生活质量的关联。

Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life.

机构信息

Department of Neurology, Harvard Medical School, Boston, MA, USA.

出版信息

Value Health. 2012 Dec;15(8):1029-35. doi: 10.1016/j.jval.2012.07.010. Epub 2012 Oct 25.


DOI:10.1016/j.jval.2012.07.010
PMID:23244804
Abstract

OBJECTIVES: To characterize work productivity in relapsing multiple sclerosis (MS) by using a work productivity scale and to identify associations between work productivity and disability, depression, fatigue, anxiety, cognition, and health-related quality of life. METHODS: Three hundred seventy-seven subjects with a clinically isolated syndrome or relapsing remitting MS participated in the study. Subjects underwent neurological examinations and completed patient-reported outcome and cognitive measures. Subjects also completed the Work Productivity and Activity Impairment Questionnaire: General Health to quantify absenteeism (missing work because of health problems), presenteeism (impairment while working), overall work impairment, and daily activity impairment attributable to health problems. Univariate correlations and multivariate models were used to determine the associations between each work productivity variable and clinical, patient-reported outcome, and cognitive measures. RESULTS: Seventy-six percent of subjects were employed. Fourteen percent of working subjects reported absenteeism, and 47% reported presenteeism. The mean work time lost because of absenteeism was 4%, and the mean work time lost because of presenteeism was 12%. Absenteeism was not significantly associated with disease or patient-reported outcome measures. Statistically significant correlations (0.32-0.53) were found between presenteeism and increasing disability, fatigue, depression, anxiety, and reduced quality of life. No associations were observed between presenteeism and disease duration or cognitive function. CONCLUSIONS: Subjects with clinically isolated syndrome/relapsing remitting MS reported substantial work productivity losses due to presenteesim. Presenteeism was associated with increasing fatigue, depression, anxiety, and reduced quality of life. It is possible that the early identification and treatment of fatigue and mental health symptoms may improve productivity while working and extend employment for individuals with MS.

摘要

目的:使用工作生产力量表来描述复发性多发性硬化症(MS)患者的工作生产力,并确定工作生产力与残疾、抑郁、疲劳、焦虑、认知和健康相关生活质量之间的关联。

方法:377 例临床孤立综合征或复发缓解型 MS 患者参与了这项研究。患者接受了神经学检查,并完成了患者报告的结局和认知测量。患者还完成了工作生产力和活动障碍问卷:一般健康,以量化因健康问题导致的旷工(因健康问题而缺勤)、在职工作障碍(工作时出现障碍)、整体工作障碍和日常活动障碍。使用单变量相关性和多变量模型来确定每个工作生产力变量与临床、患者报告的结局和认知测量之间的关联。

结果:76%的受试者有工作。14%的在职受试者报告旷工,47%报告在职工作障碍。因旷工而损失的平均工作时间为 4%,因在职工作障碍而损失的平均工作时间为 12%。旷工与疾病或患者报告的结局测量指标无显著相关性。在职工作障碍与残疾、疲劳、抑郁、焦虑和生活质量下降呈显著相关(0.32-0.53)。在职工作障碍与疾病持续时间或认知功能无相关性。

结论:患有临床孤立综合征/复发缓解型 MS 的患者因在职工作障碍而导致工作生产力大量损失。在职工作障碍与疲劳、抑郁、焦虑和生活质量下降增加有关。早期识别和治疗疲劳和心理健康症状可能会改善工作时的生产力,并延长 MS 患者的就业时间。

相似文献

[1]
Work productivity in relapsing multiple sclerosis: associations with disability, depression, fatigue, anxiety, cognition, and health-related quality of life.

Value Health. 2012-10-25

[2]
Employment and absenteeism in working-age persons with multiple sclerosis.

J Med Econ. 2017-5

[3]
Measuring productivity loss in early relapsing-remitting multiple sclerosis.

Mult Scler Relat Disord. 2022-2

[4]
Fatigue contributes to work productivity impairment in patients with axial spondyloarthritis: a cross-sectional UK study.

Clin Exp Rheumatol. 2017

[5]
Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem.

Am J Gastroenterol. 2018-9-25

[6]
Burden of relapsing-remitting multiple sclerosis on workers in the US: a cross-sectional analysis of survey data.

BMC Neurol. 2019-10-28

[7]
The capability set for work - correlates of sustainable employability in workers with multiple sclerosis.

Health Qual Life Outcomes. 2018-6-1

[8]
Self-reported work productivity in people with multiple sclerosis and its association with mental and physical health.

Disabil Rehabil. 2022-11

[9]
Factors associated with absenteeism, presenteeism and activity impairment in patients in the first years of RA.

Rheumatology (Oxford). 2011-12-16

[10]
Voice disorders in the workplace: productivity in spasmodic dysphonia and the impact of botulinum toxin.

Laryngoscope. 2013-11

引用本文的文献

[1]
Impact of Natalizumab on Productivity and Ability to Work in Patients with Multiple Sclerosis in France: The TITAN Study.

Neurol Ther. 2025-6

[2]
A cluster-randomised controlled feasibility trial evaluating the Cognitive Occupation-Based programme for people with Multiple Sclerosis (COB-MS).

Neurol Sci. 2025-1

[3]
Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective, phase IV CLADFIT-MS study.

Front Neurol. 2024-7-18

[4]
Can International Classification of Functioning, Disability and Health (ICF) Be Used for Prediction of Work Capacity and Employment Status in Multiple Sclerosis?

J Clin Med. 2024-7-18

[5]
Economic burden of multiple sclerosis in the United States: A systematic literature review.

J Manag Care Spec Pharm. 2023-12

[6]
Evaluation of Patient-Reported Outcomes in Patients with Relapsing Multiple Sclerosis Treated with Cladribine Tablets in the CLAWIR Study: 12-Month Interim Analysis.

Adv Ther. 2023-12

[7]
Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort.

Ther Adv Neurol Disord. 2023-9-8

[8]
Understanding the spectrum of non-motor symptoms in multiple sclerosis: insights from animal models.

Neural Regen Res. 2024-1

[9]
Disease-modifying therapies and cost-of-illness progression among people newly diagnosed with multiple sclerosis: a national register-based cohort study covering treatment initiation with interferons, glatiramer acetate or natalizumab.

BMJ Open. 2023-5-16

[10]
The prevalence and risk factors of anxiety in multiple sclerosis: A systematic review and meta-analysis.

Front Neurosci. 2023-4-17

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索